REALISING CAPITAL OUTCOMES
Manufactured capital


 

All the South African manufacturing sites have been declared as national key points during the year.

Manufacturing facility:

CLAYVILLE

PURPOSE

A state-of-the-art highly-automated high-volume liquids facility and a powders and effervescent plant.

BOOK VALUE

R749 million

(2017: R692 million)
property, plant and equipment

 

CAPACITY PER ANNUM

 

CAPACITY UTILISATION

 

PROGRESS DURING THE YEAR

 

28 million
Effervescent tablets

400 tonnes
Effervescent granules and
powders

 

75%
Effervescents & powders

70%
Liquids

 

All good manufacturing practice (GMP) upgrades to the general plant packing facility (Phase I) were completed during the year and all lines are up and running. A design and costing for Phase II has been prepared. The construction of the ophthalmic facility is on track for completion in the last quarter of calendar 2019.

 

12 million ℓ
Oral liquids

 

ACCREDITATIONS

South Africa (SAHPRA), Ghana (FDB), Malawi (PMPB), Kenya (PPB), Zimbabwe (MCAZ), and Ethiopia (FMHACA).

   
Manufacturing facility:

WADEVILLE

PURPOSE

A tablet and capsule facility which is focussed amongst others, on the manufacturing of anti-retroviral medicines, and a liquids, creams and ointments facility.

BOOK VALUE

R224 million

(2017: R181 million)
property, plant and equipment

 

CAPACITY PER ANNUM

 

CAPACITY UTILISATION

 

PROGRESS DURING THE YEAR

 

6 million ℓ
Oral liquids

500 tonnes
Creams/Ointments

 

80%
Liquids, creams and ointments

60%
Tablets and capsules

 

The second phase of the upgrade to the Liquids, Creams and Ointment facility was completed during the year and completion of the final phase is expected by early 2020 calendar year.

 

2 billion
Tablets and capsules

 

ACCREDITATIONS

South Africa (SAHPRA), Ghana (FDB), Malawi (PMPB), Kenya (PPB), Zimbabwe (MCAZ), and Botswana (DRU).

   
Manufacturing facility:

AEROTON

PURPOSE

The Critical Care facility produces intravenous fluids, blood collection bags, renal dialysis products and smallvolume parenterals.

BOOK VALUE

R342 million

(2017: R367 million)
property, plant and equipment

 

CAPACITY PER ANNUM

 

 

 

CAPACITY UTILISATION

 

33 million
large volume parenterals

 

4 million
pour bottles

 

100%

 

35 million
small volume parenterals

 

1 million
Blood collection bags

 

ACCREDITATIONS

South Africa (SAHPRA), and Kenya (PPB)

Manufacturing JV facility:

BANGALORE

PURPOSE

This facility produces tablets and capsules as a contract manufacturer for various pharmaceutical companies.

BOOK VALUE

R154 million

(2017: R168 million)
property, plant and equipment

 

CAPACITY PER ANNUM

 

ACCREDITATIONS

 

PROGRESS DURING THE YEAR

 

3.5 billion
Tablets and capsules

CAPACITY UTILISATION

90%

 

UK (MHRA), Australia (TGA), South Africa (SAHPRA), France (ANSM), Tanzania (TFDA), Ghana (FDB), Namibia (NMRC), Kenya (PPB), Uganda (UNDA), Ethiopia (FMHACA), Zimbabwe (MCAZ), Malawi (PMPB), and Nigeria (NAFDAC).

 

The manufacturing building (Unit 2) adjacent to the current factory, was acquired in July 2018. Construction will begin in the first quarter of the 2019 financial year and the entire capital expenditure of INR160 million will be funded from internal cash resources in the joint venture.


DISTRIBUTION

“Services to meet your needs from your door to the country and beyond.”

This year has seen the rebranding of the Distribution Division, together with the acquired Virtual Logistics business, to AVL Healthcare. AVL has an extensive national footprint, is fully compliant with pharmaceutical standards and delivers over a million units per trading day through 13 sites to hospitals, wholesalers, the Department of Health, pharmacies, clinics, healthcare practices and retail outlets.

AVL is committed to provide exceptional service through the broad range of offerings that are tailored to meet specific customer needs.

DISTRIBUTION CENTRES AND/OR HUBS ARE IN THE FOLLOWING AREAS

  • Midrand (2)
  • Aeroton
  • Clayville
  • Cape Town
  • Durban
  • Bloemfontein
  • Port Elizabeth
  • Nelspruit
  • Polokwane
  • Kimberley
  • East London
  • Ladysmith

THE BROAD RANGE OF DISTRIBUTION SERVICES INCLUDE

Bulk

We have invested heavily in bulk warehouse storage, allowing us to meet customers’ bulk requirements every step of the way. Regardless of pallet quantity, we offer deliveries, inter-depot transfers and line haul service.

Fine

We deliver directly to healthcare customers, be they doctors, pharmacies, clinics, hospitals or wholesalers. Our state-of-the-art fine picking system allows us to better manage our warehouse throughput and provide a comprehensive logistics solution for our partners.

Retail

In the fast turnaround retail industry, the importance of efficient and reliable logistics cannot be over-emphasised. We offer fast, reliable delivery to all back-door retail outlets and distribution centres.

Cold chain

We offer validated fridge-to-fridge (in-vehicle) delivery capability at 2 – 8 degrees Celsius and are able to supply validated cold chain boxes. This ensures that temperature-sensitive deliveries are never compromised, no matter where they are along the supply chain.

Cold chain

We have invested heavily in bulk warehouse storage, allowing us to meet customers’ bulk requirements every step of the way. Regardless of pallet quantity, we offer deliveries, inter-depot transfers and line haul service.

Fixed fleet

We offer the supply and management of dedicated and validated healthcare specific fleet solutions. Our trucks are an extension of our warehouses, and offer a consistent and controlled environment at all times. Our fleet is validated and temperature controlled, our drivers are trained on standards operating procedure (SOP’s) and all trucks are tracked on a transport management system (TMS).

Inter-depot transfers

We offer compliant inter-depot transfers around the country.

Home patients

We offer delivery direct to patients for the Adcock Ingram Critical Care renal division.

Reverse logistics

We offer effective, professional management of customer returns.

Warehousing

Our warehousing solutions are designed to ensure a consistent storage environment for all pharmaceutical products.

Cross-border

Our footprint includes cross-border delivery. We offer direct loads and break-bulk loads to SADC countries.

Making a home delivery to a renal patient.

Making a home delivery to a renal patient.